Pentokey Organy India Ltd vs Strides Pharma Science Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 15, 2026

Key Highlights

The Latest Trading Price of Pentokey Organy (India) Ltd is ₹ 36.55 as of 12 Jun 15:30 . The P/E Ratio of Pentokey Organy (India) Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Strides Pharma Science Ltd changed from 28.2 on March 2021 to 1.7 on March 2025 . This represents a CAGR of -42.98% over 5 years The Market Cap of Pentokey Organy (India) Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Strides Pharma Science Ltd changed from ₹ 7573 crore on March 2021 to ₹ 6165 crore on March 2025 . This represents a CAGR of -4.03% over 5 years The revenue of Pentokey Organy (India) Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Strides Pharma Science Ltd for the Mar '26 is ₹ 1333 crore as compare to the Dec '25 revenue of ₹ 1301 crore. This represent the growth of 2.42% The ebitda of Pentokey Organy (India) Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Strides Pharma Science Ltd for the Mar '26 is ₹ 242.88 crore as compare to the Dec '25 ebitda of ₹ 339.48 crore. This represent the decline of -28.46% The net profit of Pentokey Organy (India) Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Strides Pharma Science Ltd changed from ₹ 3349 crore to ₹ 129.28 crore over 8 quarters. This represents a CAGR of -80.35% The Dividend Payout of Pentokey Organy (India) Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Strides Pharma Science Ltd changed from 28.66 % on March 2021 to 1.28 % on March 2025 . This represents a CAGR of -46.30% over 5 years .

About Pentokey Organy (India) Ltd

Pentokey Organy (India) Limited was incorporated on November 26, 1986.
The Company is engaged in the trading of Pharmaceutical products such as Acetic Acid, Ethyl Acetate and Acetaldehyde.
Ethyl Acetate is preferred by customers in all markets as it is fast replacing the petroleum-based solvents such as Toluene, MEK (Methyl Ethyl Ketone), MIBK (Methyl Iso Butyl Ketone) etc. In 2012-13, the production of intermediate product namely Acetic Acid was not competitive due to market prices.
Company therefore purchased the Acetic Acid from market instead of producing the same from Ethanol or Acetaldehyde.
As a result of this, production of Acetaldehyde, which is an intermediate product for Acetic Acid, was low.

About Strides Pharma Science Ltd

Strides Pharma Science Limited was originally incorporated under the name 'Strides Arcolab Limited ' on June 28, 1990.
In FY 2016, Shasun Pharmaceuticals Limited merged with Strides Arcolab Limited forming a new identity 'Strides Shasun Limited', making it effective from 19 November, 2015 and name of the Company was changed to 'Strides Pharma Science Limited' from 'Strides Shasun Limited' effective on July 18, 2018. Strides Pharma Science is a global pharmaceutical company headquartered in Bengaluru, India.
The Company is an integrated manufacturer and exporter of Finished Pharmaceutical Dosage forms for both branded and generic.
It manufactures a very wide spectrum of ethical pharmaceutical products, OTC products and nutraceuticals.
Their dosage forms range includes tablets, capsules, soft gelatin capsules, parenterals and semisolids.

FAQs for the comparison of Pentokey Organy (India) Ltd and Strides Pharma Science Ltd

Which company has a larger market capitalization, Pentokey Organy (India) Ltd or Strides Pharma Science Ltd?

Market cap of Pentokey Organy (India) Ltd is 22 Cr while Market cap of Strides Pharma Science Ltd is 9,717 Cr

What are the key factors driving the stock performance of Pentokey Organy (India) Ltd and Strides Pharma Science Ltd?

The stock performance of Pentokey Organy (India) Ltd and Strides Pharma Science Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Pentokey Organy (India) Ltd and Strides Pharma Science Ltd?

As of June 15, 2026, the Pentokey Organy (India) Ltd stock price is INR ₹36.55. On the other hand, Strides Pharma Science Ltd stock price is INR ₹1054.3.

How do dividend payouts of Pentokey Organy (India) Ltd and Strides Pharma Science Ltd compare?

To compare the dividend payouts of Pentokey Organy (India) Ltd and Strides Pharma Science Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.